(Q53585661)

15 May 2018

title

Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. (English)

1 reference

15 May 2018

1 reference

1 reference

6

1 reference

15 May 2018

author name string

Esper P

1

1 reference

15 May 2018

Mo F

2

1 reference

15 May 2018

Chodak G

3

1 reference

15 May 2018

Sinner M

4

1 reference

15 May 2018

Cella D

5

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 December 1997

1 reference

15 May 2018

published in

Urology

1 reference

15 May 2018

volume

50

1 reference

15 May 2018

issue

6

1 reference

15 May 2018

page(s)

920-928

1 reference

15 May 2018

cites work

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Management of relapsing disease in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Correlates of stress in HIV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

The influence of stress management training in HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Quality of life and functional status measures in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900459-7

7 January 2021

10.1016/S0090-4295(97)00459-7

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018